Systematic reviews of convalescent plasma in COVID-19 continue to be poorly conducted and reported: a systematic review

[1]  Kendra Godwin,et al.  Assessing journal author guidelines for systematic reviews and meta-analyses: findings from an institutional sample , 2022, Journal of the Medical Library Association : JMLA.

[2]  E. Akl,et al.  Challenges of evidence synthesis during the 2020 COVID pandemic: a scoping review , 2021, Journal of Clinical Epidemiology.

[3]  C. Roche,et al.  Engaging stakeholders with evidence and uncertainty: developing a toolkit , 2021 .

[4]  Carrie Forbes,et al.  The effect of librarian involvement on the quality of systematic reviews in dental medicine , 2021, PloS one.

[5]  T. Lorenc,et al.  Cost-effectiveness of Microsoft Academic Graph with machine learning for automated study identification in a living map of coronavirus disease 2019 (COVID-19) research. , 2021, Wellcome open research.

[6]  Robin Featherstone,et al.  Machine learning reduced workload for the Cochrane COVID-19 Study Register: development and evaluation of the Cochrane COVID-19 Study Classifier , 2021, Systematic Reviews.

[7]  D. Moher,et al.  Improving peer review of systematic reviews by involving librarians and information specialists: protocol for a randomized controlled trial , 2021, Trials.

[8]  J. Thompson Coon,et al.  Characteristics, quality and volume of the first 5 months of the COVID-19 evidence synthesis infodemic: a meta-research study , 2021, BMJ Evidence-Based Medicine.

[9]  E. Wood,et al.  Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. , 2021, The Cochrane database of systematic reviews.

[10]  C. Allen,et al.  Communication vs evidence: What hinders the outreach of science during an infodemic? A narrative review , 2021, Integrative Medicine Research.

[11]  Lifeng Lin,et al.  Methodological assessment of systematic reviews and meta‐analyses on COVID‐19: A meta‐epidemiological study , 2021, Journal of evaluation in clinical practice.

[12]  D. Moher,et al.  PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews , 2021, Journal of the Medical Library Association : JMLA.

[13]  Patrick W. Johnson,et al.  Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence , 2021, Frontiers in Medicine.

[14]  Yu Qin,et al.  Reporting and methodological quality of COVID-19 systematic reviews needs to be improved: an evidence mapping , 2021, Journal of Clinical Epidemiology.

[15]  S. Goodman,et al.  Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis. , 2021, JAMA.

[16]  G. Carrasco,et al.  Use of convalescent plasma in patients with coronavirus disease (Covid-19): Systematic review and meta-analysis , 2021, medRxiv.

[17]  J. Sanz-Cánovas,et al.  Treatment of COVID-19 with convalescent plasma in patients with humoral immunodeficiency – Three consecutive cases and review of the literature , 2021, Enfermedades Infecciosas y Microbiología Clínica.

[18]  M. D. dos Santos,et al.  The mass production of systematic reviews about COVID‐19: An analysis of PROSPERO records , 2021, Journal of evidence-based medicine.

[19]  X. Jouven,et al.  COVID-19-related medical research: a meta-research and critical appraisal , 2021, BMC Medical Research Methodology.

[20]  M. Franchini,et al.  The use of convalescent plasma for pediatric patients with SARS-CoV-2: A systematic literature review , 2020, Transfusion and Apheresis Science.

[21]  J. Ioannidis,et al.  The rapid, massive growth of COVID-19 authors in the scientific literature , 2020, bioRxiv.

[22]  Sajjad Ali,et al.  Convalescent Plasma Therapy and its Century-Old Untapped Potential for COVID-19 , 2020 .

[23]  A. Casadevall,et al.  Therapeutic use of convalescent plasma in COVID-19 patients with immunodeficiency: A systematic review , 2020, medRxiv.

[24]  J. Anaya,et al.  Why will it never be known if convalescent plasma is effective for COVID-19 , 2020, Journal of Translational Autoimmunity.

[25]  E. Wood,et al.  Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. , 2020, The Cochrane database of systematic reviews.

[26]  Robin Christensen,et al.  Using an Evidence-Based Research approach before a new study is conducted to ensure value. , 2020, Journal of clinical epidemiology.

[27]  Robin Christensen,et al.  Using an Evidence-Based Research approach to place your results into context after the study is performed to ensure usefulness of the conclusion. , 2020, Journal of clinical epidemiology.

[28]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2020, BMJ.

[29]  Isabela Barbosa Dos santos,et al.  Plasma convalescente como alternativa ao tratamento aplicado à Covid-19 , 2020 .

[30]  F. Klamt,et al.  Convalescent Plasma Therapy on Patients with Severe or Life-Threatening COVID-19: A Metadata Analysis , 2020, The Journal of infectious diseases.

[31]  O. Bruyère,et al.  Methodological quality of meta-analyses indexed in PsycINFO: leads for enhancements: a meta-epidemiological study , 2020, BMJ Open.

[32]  Nicole M. Bouvier,et al.  Evidence favouring the efficacy of convalescent plasma for COVID-19 therapy , 2020, medRxiv.

[33]  N. Bagdasarian,et al.  Rapid publications risk the integrity of science in the era of COVID-19 , 2020, BMC Medicine.

[34]  Mujahed I. Mustafa,et al.  Convalescent Plasma a Potential Therapy in Covid-19 Patients in Low Resource Setting: Rapid Review , 2020 .

[35]  Neal R Haddaway,et al.  “One more time”: why replicating some syntheses of evidence relevant to COVID-19 makes sense , 2020, Journal of Clinical Epidemiology.

[36]  E. Wood,et al.  Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review. , 2020, The Cochrane database of systematic reviews.

[37]  T. Hoffmann,et al.  Waste in covid-19 research , 2020, BMJ.

[38]  X. Basagaña,et al.  Adherence to reporting guidelines increases the number of citations: the argument for including a methodologist in the editorial process and peer-review , 2019, BMC Medical Research Methodology.

[39]  D. Pieper,et al.  Systematic reviews with published protocols compared to those without: more effort, older search. , 2018, Journal of clinical epidemiology.

[40]  Spyridon N Papageorgiou,et al.  Registration in the international prospective register of systematic reviews (PROSPERO) of systematic review protocols was associated with increased review quality. , 2018, Journal of clinical epidemiology.

[41]  David Moher,et al.  Evaluations of the uptake and impact of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Statement and extensions: a scoping review , 2017, Systematic Reviews.

[42]  P. Tugwell,et al.  AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both , 2017, British Medical Journal.

[43]  P. Shekelle,et al.  Implementing PRISMA-P: recommendations for prospective authors , 2016, Systematic Reviews.

[44]  Gary D. Bader,et al.  Cytoscape.js: a graph theory library for visualisation and analysis , 2015, Bioinform..

[45]  Melissa L Rethlefsen,et al.  Librarian co-authors correlated with higher quality reported search strategies in general internal medicine systematic reviews. , 2015, Journal of clinical epidemiology.

[46]  S. Staniszewska,et al.  Mapping the impact of patient and public involvement on health and social care research: a systematic review , 2014, Health expectations : an international journal of public participation in health care and health policy.

[47]  Walter Ricciardi,et al.  Evaluation of the Endorsement of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) Statement on the Quality of Published Systematic Review and Meta-Analyses , 2013, PloS one.

[48]  Ying Ding,et al.  Applying centrality measures to impact analysis: A coauthorship network analysis , 2009, J. Assoc. Inf. Sci. Technol..

[49]  Fred L. Drake,et al.  Python 3 Reference Manual , 2009 .

[50]  Aric Hagberg,et al.  Exploring Network Structure, Dynamics, and Function using NetworkX , 2008, Proceedings of the Python in Science Conference.

[51]  F. Masoumi,et al.  Short Communication Treatment with convalescent plasma for COVID-19 with respect to experience from prior coronavirus epidemics , 2021 .

[52]  Ian Shemilt.  Machine Learning Reduced Workload for the Cochrane COVID-19 Study Register : Development and Evaluation of the Cochrane COVID-19 Study Classi � er , 2021 .

[53]  Società Italiana di Emaferesi.  Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis , 2001 .

[54]  W. Laing.  Cost effectiveness. , 1979, Journal of medical engineering & technology.

[55]  Use of convalescent plasma in patients with coronavirus disease (Covid-19): Systematic review and meta-analysis , 2022 .